Wednesday, 28 October 202611:19 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

What are SGLT2 Inhibitors?

Image: Crackittoday. Rights remain with the publisher.

What are SGLT2 Inhibitors? New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). SGLT2 (Sodium-Glucose Cotransporter-2) inhibitors are a class of medications primarily used to treat Type 2 diabetes (T2D).

T2D, the most common type of diabetes, is

Read the full report on Crackittoday

Story file

Section
Health
Topics
Health alerts
First reported by
Crackittoday
Reporter
kumari sonali
Published
Wednesday, 28 October 2026, 9:28 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Crackittoday with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all